Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms × Ibuprofen × Clear all

Phase

Phase 2 3 Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Follicular 2 Neoplasms 1 Mucositis 1 Inflammation 1 Head and Neck Neoplasms 1 Cachexia 1 Breast Neoplasms 1 Abnormalities, Radiation-Induced 1

Interventions

Paclitaxel 19 Dexamethasone 16 Bevacizumab 16 Oxaliplatin 14 Docetaxel 14 Cyclophosphamide 12 Capecitabine 12 Gemcitabine 11 Sorafenib 10 Leucovorin 10 Fluorouracil 10 Carboplatin 10 Epoetin Alfa 9 pembrolizumab 8 Pemetrexed 8 Fentanyl 8 venetoclax 7 atezolizumab 7 Prednisone 7 Rivaroxaban 6 Ondansetron 6 Morphine 6 Irinotecan 6 Drug Therapy 6 Doxorubicin 6 Denosumab 6 Cisplatin 6 Tranexamic Acid 5 Sodium Chloride 5 Panitumumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02330926 2025-08-29

MENAC

Norwegian University of Science and Technology

Phase 3 Completed

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡